p16 promoter hypermethylation in human hepatocellular carcinoma with or without hepatitis virus infection

Intervirology

Volumn 47, Issue 1, 2004, Pages 26-31

  Narimatsu, Takashi ^a   Tamori, Akihiro ^a   Koh, Noritoshi ^a   Kubo, Shoji ^a   Hirohashi, Kazuhiro ^a   Yano, Yoshihisa ^a   Arakawa, Tetsuo ^a   Otani, Shuzo ^a   Nishiguchi, Shuhei ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Hepatitis virus; Hepatocellular carcinoma; Methylation; p16; p53

Indexed keywords

PROTEIN P16; PROTEIN P53;

ADULT; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENE SEQUENCE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; METHYLATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; VIRUS INFECTION;

CARCINOMA, HEPATOCELLULAR; DNA METHYLATION; FEMALE; GENES, P16; GENES, P53; HEPATITIS B; HEPATITIS C; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MUTATION; PROMOTER REGIONS (GENETICS);

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 1842454118     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000076639     Document Type: Article

References (23)

1. Feitelson MA, Zhu M, Duan LX, London WT: Hepatitis B x antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma. Oncogene 1993;8:1109-1117.
2. Han HJ, Jung EY, Lee WJ, Jang KL: Cooperative repression of cyclin-dependent kinase inhibitor p21 gene expression by hepatitis B virus X protein and hepatitis C virus core protein. FEBS Lett 2002;518:169-172.
3. Yoshida I, Oka K, Hidajat R, Nagano-Fujii M, Ishido S, Hotta H: Inhibition of p21/Waf1/Cip1/Sdi1 expression by hepatitis C virus core protein. Microbiol Immunol 2001;45:689-697.
4. Moriya K, Fujie H, Shintani Y, Yotsuyanagi H, Tsutsumi T, Ishibashi K, Matsuura Y, Kimura S, Miyamura T, Koike K: The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 1998;4:1065-1067.
5. Kim CM, Koike K, Saito I, Miyamura T, Jay G: HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 1991;351:317-320.
6. Hayashi H, Sugio K, Matsumata T, Adachi E, Takenaka K, Sugimachi K: The clinical significance of p53 gene mutation in hepatocellular carcinomas from Japan. Hepatology 1995;22:1702-1707.
7. Oda T, Tsuda H, Scarpa A, Sakamoto M, Hirohashi S: p53 gene mutation spectrum in hepatocellular carcinoma. Cancer Res 1992;52:6358-6364.
8. Tannapfel A, Busse C, Weinans L, Benicke M, Katalinic A, Geissler F, Hauss J, Wittekind C: INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas. Oncogene 2001;20:7104-7109.
9. Matsumura T, Makino R, Mitamura K: Frequent down-regulation of E-cadherin by genetic and epigenetic changes in the malignant progression of hepatocellular carcinomas. Clin Cancer Res 2001;7:594-599.
10. Sun L, Hui AM, Kanai Y, Sakamoto M, Hirohashi S: Increased DNA methyltransferase expression is associated with an early stage of human hepatocarcinogenesis. Jpn J Cancer Res 1997;88:1165-1170.
11. Esteller M: CpG island hypermethylation and tumor suppressor genes: A booming present, a brighter future. Oncogene 2002;21:5427-5440.
12. Iwata N, Yamamoto H, Sasaki S, Itoh F, Suzuki H, Kikuchi T, Kaneto H, Iku S, Ozeki I, Karino Y, Satoh T, Toyota J, Satoh M, Endo T, Imai K: Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma. Oncogene 2000;19:5298-5302.
13. Wang L, Bani-Hani A, Montoya DP, Roche PC, Thibodeau SN, Burgart LJ, Roberts LR: hMLH1 and hMSH2 expression in human hepatocellular carcinoma. Int J Oncol 2001;19:567-570.
14. Matsuda Y, Ichida T, Matsuzawa J, Sugimura K, Asakura H: p16(INK4) is inactivated by extensive CpG methylation in human hepatocellular carcinoma. Gastroenterology 1999;116:394-400.
15. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB: Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996;93:9821-9826.
16. Roncalli M, Bianchi P, Bruni B, Laghi L, Destro A, Di Gioia S, Gennari L, Tommasini M, Malesci A, Coggi G: Methylation framework of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinoma. Hepatology 2002;36:427-432.
17. Liew CT, Li HM, Lo KW, Leow CK, Chan JY, Hin LY, Lau WY, Lai PB, Lim BK, Huang J, Leung WT, Wu S, Lee JC: High frequency of p16INK4A gene alterations in hepatocellular carcinoma. Oncogene 1999;18:789-795.
18. Kaneto H, Sasaki S, Yamamoto H, Itoh F, Toyota M, Suzuki H, Ozeki I, Iwata N, Ohmura T, Satoh T, Karino Y, Satoh T, Toyota J, Satoh M, Endo T, Omata M, Imai K: Detection of hypermethylation of the p16(INK4A) gene promoter in chronic hepatitis and cirrhosis associated with hepatitis B or C virus. Gut 2001;48:372-377.
19. Zhong S, Tang MW, Yeo W, Liu C, Lo YM, Johnson PJ: Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas. Clin Cancer Res 2002;8:1087-1092.
20. Shen L, Ahuja N, Shen Y, Habib NA, Toyota M, Rashid A, Issa JP: DNA methylation and environmental exposures in human hepatocellular carcinoma. J Natl Cancer Inst 2002;94:755-761.
21. Ambinder RF, Robertson KD, Tao Q: DNA methylation and the Epstein-Barr virus. Semin Cancer Biol 1999;9:369-375.
22. Remus R, Kammer C, Heller H, Schmitz B, Schell G, Doerfler W: Insertion of foreign DNA into an established mammalian genome can alter the methylation of cellular DNA sequences. J Virol 1999;73:1010-1022.
23. Yeh SH, Chen PJ, Shau WY, Chen YW, Lee PH, Chen JT, Chen DS: Chromosomal allelic imbalance evolving from liver cirrhosis to hepatocellular carcinoma. Gastroenterology 2001;121:699-709.